30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q13 Revenue: Smith & Nephew

Advanced Surgical Devices $760MM, -2% (U.S. -2%, Established Markets -7%, Emerging/International Markets +16%)

  • Hips $167MM, -6% (-3% excluding Birmingham Hip) (U.S. -8%, ex-U.S. -4%)
  • Knees $219MM, -6% (U.S. -5%, ex-U.S. -8%)
  • Sports Medicine Joint Repair $120MM, +4%
  • Arthroscopic Enabling Technologies $110MM, -7%
  • Trauma $124MM, +8%
  • Other $20MM, +6%


  • Like-for-like pricing pressure unchanged; almost no erosion in SportsMed
  • Europe represents ~30% of total company revenue
  • Announced intent to acquire Adler Mediequip and Sushrut Surgicals, manufacturer and distributor of mid-tier trauma products in India, following agreement to acquire distribution business in Brazil; cost of both acquisitions is ~$70MM
  • Ramping up investment in Journey II BCS Knee launch
  • Added >50 new trauma and extremity sales reps
  • Launched new Modular Rail for external fixation/deformity correction
  • 2Q launches include REDAPT Hip Revision Femoral System in Europe, Active Heel Traction Boot, ALL 28 foot/ankle portfolio expansion (including ankle instability, Achilles tendon repair)